This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Arch Development Corporation, Ur Labs, Inc., Other. Active years: 1999-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1999-2003
Title: Joseph F Foss: Innovator in Opioid Treatment
Introduction
Joseph F Foss is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of opioid-induced side effects. With a total of 4 patents to his name, Foss has focused on innovative methods to improve patient care.
Latest Patents
Foss's latest patents include groundbreaking methods for preventing or treating opioid-induced changes in gastrointestinal motility. One of his notable inventions involves the use of methylnaltrexone or related compounds. This method comprises administering methylnaltrexone or another quaternary derivative of noroxymorphone to a patient prior to the administration of an opioid or after the onset of side effects induced by the administration of an opioid. The administration is done orally in an enterically coated form. Another significant patent addresses the treatment of chronic opioid use side effects. This method involves administering a quaternary derivative of noroxymorphone in an amount sufficient to prevent or treat the side effect in a patient who has been chronically taking opioids.
Career Highlights
Throughout his career, Foss has worked with various organizations, including Arch Development Corporation. His work has been instrumental in advancing the understanding and treatment of opioid-related issues.
Collaborations
Foss has collaborated with notable individuals in his field, including Michael F Roizen and Jonathan Moss. Their combined expertise has contributed to the development of effective treatment methods.
Conclusion
Joseph F Foss stands out as an innovator dedicated to improving the lives of patients dealing with the challenges of opioid use. His patents reflect a commitment to advancing medical science and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile